For localized information and support, would you like to switch to your country-specific website for {0}?
Key takeaways
- Strong International presence at AAIC: Over 10,000 attendees from more than 135 countries came together to shape the future of Alzheimer's disease and dementia
- Fully booked Roche Dia Symposium “Closing the Diagnostic Gap: Utilizing pTau217 for Scalable Alzheimer's Disease Diagnosis” featuring international speakers (Alicia Algeciras Schimnich, Craig Ritchie & Nicholas Ashton)
- Inside ‘The Floral Sanctuary’: Roche’s immersive living art space at the booth inviting reflection on the ongoing fight against Alzheimer’s disease
Save Time, Save Minds
The AAIC Congress in London has officially concluded. We want to warmly thank everyone who visited our booth and attended our scientific sessions. The energy, dialogue, and collaboration throughout the event brought forward a wealth of invaluable insights and key learnings.
Addressing the global burden of Alzheimer’s disease requires more than innovative tests and treatments. That is why we proudly partner with clinicians, scientists, patient advocates, policymakers, and health systems. Collaborative moments like the AAIC Congress allow us to gain the collective insights needed to ensure that advances in Alzheimer’s research translate into meaningful, real-world benefits for millions of people worldwide.
Relive our diagnostics symposium
In case you did not make it to our satellite symposium or simply want to revisit the experience, the recording is available here. This video features expert insights from Alicia Algeciras-Schimnich, Prof. Craig Ritchie and Prof. Nick Ashton. They highlight key discussions on the role of blood-based biomarkers—such as pTau217—in bridging the diagnostic gap, enabling earlier detection, and expanding global access to disease-modifying therapies.
We look forward to continuing these vital conversations and working together to shape the future of Alzheimer's care.
Meet the speakers
Chairperson: Prof. Alicia Algeciras Schimnich
Professor of Laboratory Medicine and Pathology at Mayo Clinic Rochester
Rochester, Minnesota, United States
Speaker: Prof. Craig Ritchie
MBChB PhD MSc FRCP(Edin) MRCPsych
CEO and Founder: Scottish Brain Sciences
Professor of Brain Health and Neurodegenerative Medicine: University of St Andrews.
Edinburgh, UK
Speaker: Prof. Nick Ashton
Senior Director Fluid Biomarker program at Banner Sun Health Research Institute
Sun City, Arizona, United States